Interleukin 4 and STAT6 gene polymorphisms are associated with systemic lupus erythematosus in Chinese patients

Lupus

Volumn 19, Issue 10, 2010, Pages 1219-1228

  Yu, H H ^a   Liu, P H ^b   Lin, Y C ^a   Chen, W J ^b   Lee, J H ^a   Wang, L C ^a   Yang, Y H ^a   Chiang, B L ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

cytokine; gene polymorphism; IL18; IL4; STAT6; systemic lupus erythematosus

Indexed keywords

CYTOKINE; INTERLEUKIN 4; STAT6 PROTEIN;

ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC LUPUS ERYTHEMATOSUS; TH1 CELL; TH2 CELL;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-4; LOGISTIC MODELS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK; STAT6 TRANSCRIPTION FACTOR;

EID: 77956239438     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310371152     Document Type: Article

References (48)

1. Rahman A., Isenberg DA Systemic lupus erythematosus. N Engl J Med 2008 ; 358: 929-939.
2. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 1996 ; 17: 138-146.
3. Balomenos D., Rumold R., Theofilopoulos AN Interferon-gamma is required for lupus-like disease and lymphoaccumulation in MRLlpr mice. J Clin Invest 1998 ; 101: 364-371.
4. Peng SL, Moslehi J., Craft J. Roles of interferon-gamma and interleukin-4 in murine lupus. J Clin Invest 1997 ; 99: 1936-1946.
5. Santiago ML, Fossati L., Jacquet C., Muller W., Izui S., Reininger L. Interleukin-4 protects against a genetically linked lupus-like autoimmune syndrome. J Exp Med 1997 ; 185: 65-70.
6. Schorlemmer HU, Dickneite G., Kanzy EJ, Enssle KH. Modulation of the immunoglobulin dysregulation in GvH- and SLE-like diseases by the murine IL-4 receptor (IL-4-R). Inflamm Res 1995 ; 44 (Suppl 2). S194 - S196.
7. Ishida H., Muchamuel T., Sakaguchi S., Andrade S., Menon S., Howard M. Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 1994 ; 179: 305-310.
8. Lit LC, Wong CK, Li EK, Tam LS, Lam CW, Lo YM Elevated gene expression of Th1/Th2 associated transcription factors is correlated with disease activity in patients with systemic lupus erythematosus. J Rheumatol 2007 ; 34: 89-96.
9. Sugimoto K., Morimoto S., Kaneko H., et al. Decreased IL-4 producing CD4+ T cells in patients with active systemic lupus erythematosus-relation to IL-12R expression. Autoimmunity 2002 ; 35: 381-387.
10. Tokano Y., Morimoto S., Kaneko H., et al. Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)-relation to Th1- and Th2-derived cytokines. Clin Exp Immunol 1999 ; 116: 169-173.
11. Goldman M., Druet P., Gleichmann E. TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity. Immunol Today 1991 ; 12: 223-227.
12. Funauchi M., Ikoma S., Enomoto H., Horiuchi A. Decreased Th1-like and increased Th2-like cells in systemic lupus erythematosus. Scand J Rheumatol 1998 ; 27: 219-224.
13. Csiszar A., Nagy G., Gergely P., Pozsonyi T., Pocsik E. Increased interferon-gamma (IFN-gamma), IL-10 and decreased IL-4 mRNA expression in peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 2000 ; 122: 464-470.
14. Gomez D., Correa PA, Gomez LM, Cadena J., Molina JF, Anaya JM Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum 2004 ; 33: 404-413.
15. Viallard JF, Pellegrin JL, Ranchin V., et al. Th1 (IL-2, interferon-gamma (IFN-gamma)) and Th2 (IL-10, IL-4) cytokine production by peripheral blood mononuclear cells (PBMC) from patients with systemic lupus erythematosus (SLE). Clin Exp Immunol 1999 ; 115: 189-195.
16. Wong CK, Ho CY, Li EK, Lam CW Elevation of proinflammatory cytokine (IL-18, IL-17, IL-12) and Th2 cytokine (IL-4) concentrations in patients with systemic lupus erythematosus. Lupus 2000 ; 9: 589-593.
17. Calvani N., Tucci M., Richards HB, Tartaglia P., Silvestris F. Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 2005 ; 4: 542-548.
18. Wu MC, Huang CM, Tsai JJ, Chen HY, Tsai FJ Polymorphisms of the interleukin-4 gene in Chinese patients with systemic lupus erythematosus in Taiwan. Lupus 2003 ; 12: 21-25.
19. Kanemitsu S., Takabayashi A., Sasaki Y., et al. Association of interleukin-4 receptor and interleukin-4 promoter gene polymorphisms with systemic lupus erythematosus. Arthritis Rheum 1999 ; 42: 1298-1300.
20. Schotte H., Schluter B., Rust S., Assmann G., Domschke W., Gaubitz M. Interleukin-6 promoter polymorphism (-174 G/C) in Caucasian German patients with systemic lupus erythematosus. Rheumatology (Oxford) 2001 ; 40: 393-400.
21. Lee YH, Harley JB, Nath SK Meta-analysis of TNF-alpha promoter -308 A/G polymorphism and SLE susceptibility. Eur J Hum Genet 2006 ; 14: 364-371.
22. Parks CG, Cooper GS, Dooley MA, et al. Systemic lupus erythematosus and genetic variation in the interleukin 1 gene cluster: a population based study in the southeastern United States. Ann Rheum Dis 2004 ; 63: 91-94.
23. Chong WP, Ip WK, Wong WH, Lau CS, Chan TM, Lau YL Association of interleukin-10 promoter polymorphisms with systemic lupus erythematosus. Genes Immun 2004 ; 5: 484-492.
24. Sanchez E., Palomino-Morales RJ, Ortego-Centeno N., et al. Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus. Hum Mol Genet 2009 ; 18: 3739-3748.
25. Lin YJ, Wan L., Lee CC, et al. Disease association of the interleukin-18 promoter polymorphisms in Taiwan Chinese systemic lupus erythematosus patients. Genes Immun 2007 ; 8: 302-307.
26. Lin YJ, Wan L., Sheu JJ, et al. A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients. Lupus 2008 ; 17: 124-127.
27. Moore JH The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum Hered 2003 ; 56: 73-82.
28. Hulkkonen J., Pertovaara M., Antonen J., Lahdenpohja N., Pasternack A., Hurme M. Genetic association between interleukin-10 promoter region polymorphisms and primary Sjogren's syndrome. Arthritis Rheum 2001 ; 44: 176-179.
29. Seegers D., Zwiers A., Strober W., Pena AS, Bouma G. A TaqI polymorphism in the 3'UTR of the IL-12 p40 gene correlates with increased IL-12 secretion. Genes Immun 2002 ; 3: 419-423.
30. Giedraitis V., He B., Huang WX, Hillert J. Cloning and mutation analysis of the human IL-18 promoter: a possible role of polymorphisms in expression regulation. J Neuroimmunol 2001 ; 112: 146-152.
31. Vercelli D. Genetics of IL-13 and functional relevance of IL-13 variants. Curr Opin Allergy Clin Immunol 2002 ; 2: 389-393.
32. Rosenwasser LJ, Klemm DJ, Dresback JK, et al. Promoter polymorphisms in the chromosome 5 gene cluster in asthma and atopy. Clin Exp Allergy 1995 ; 25 (Suppl 2). 74-78 ; discussion 95-76.
33. Schedel M., Carr D., Klopp N., et al. A signal transducer and activator of transcription 6 haplotype influences the regulation of serum IgE levels. J Allergy Clin Immunol 2004 ; 114: 1100-1105.
34. Hochberg MC Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997 ; 40: 1725.
35. Yang HC, Lin CH, Hsu CL, et al. A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci 2006 ; 13: 489-498.
36. Wang IJ, Chiang TH, Shih YF, et al. The association of single nucleotide polymorphisms in the MMP-9 genes with susceptibility to acute primary angle closure glaucoma in Taiwanese patients. Mol Vis 2006 ; 12: 1223-1232.
37. Klipper-Aurbach Y., Wasserman M., Braunspiegel-Weintrob N., et al. Mathematical formulae for the prediction of the residual beta cell function during the first two years of disease in children and adolescents with insulin-dependent diabetes mellitus. Med Hypotheses 1995 ; 45: 486-490.
38. Tregouet DA, Garelle V. A new JAVA interface implementation of THESIAS: testing haplotype effects in association studies. Bioinformatics 2007 ; 23: 1038-1039.
39. Hahn LW, Ritchie MD, Moore JH Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 2003 ; 19: 376-382.
40. Motsinger AA, Brassat D., Caillier SJ, et al. Complex gene-gene interactions in multiple sclerosis: a multifactorial approach reveals associations with inflammatory genes. Neurogenetics 2007 ; 8: 11-20.
41. Schedel M., Frei R., Bieli C., et al. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression. J Allergy Clin Immunol 2009 ; 124: 583-589.
42. Kabesch M., Schedel M., Carr D., et al. IL-4/IL-13 pathway genetics strongly influence serum IgE levels and childhood asthma. J Allergy Clin Immunol 2006 ; 117: 269-274.
43. Nelms K., Keegan AD, Zamorano J., Ryan JJ, Paul WE The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999 ; 17: 701-738.
44. Erb KJ, Ruger B., von Brevern M., Ryffel B., Schimpl A., Rivett K. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J Exp Med 1997 ; 185: 329-339.
45. Singh RR, Saxena V., Zang S., et al. Differential contribution of IL-4 and STAT6 vs STAT4 to the development of lupus nephritis. J Immunol 2003 ; 170: 4818-4825.
46. Nagy G., Pallinger E., Antal-Szalmas P., et al. Measurement of intracellular interferon-gamma and interleukin-4 in whole blood T lymphocytes from patients with systemic lupus erythematosus. Immunol Lett 2000 ; 74: 207-210.
47. Xu Q., Tin SK, Sivalingam SP, Thumboo J., Koh DR, Fong KY Interleukin-18 promoter gene polymorphisms in Chinese patients with systemic lupus erythematosus: association with CC genotype at position -607. Ann Acad Med Singapore 2007 ; 36: 91-95.
48. Chen DY, Hsieh CW, Chen KS, Chen YM, Lin FJ, Lan JL Association of interleukin-18 promoter polymorphisms with WHO pathological classes and serum IL-18 levels in Chinese patients with lupus nephritis. Lupus 2009 ; 18: 29-37.